Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Preanalytical stability of [-2]proPSA in whole blood stored at room temperature before separation of serum and plasma: implications to Phi determination.

Dittadi R, Fabricio ASC, Rainato G, Peroni E, Di Tonno F, Vezzù B, Mazzariol C, Squarcina E, Tammone L, Gion M.

Clin Chem Lab Med. 2018 Sep 15. pii: /j/cclm.ahead-of-print/cclm-2018-0596/cclm-2018-0596.xml. doi: 10.1515/cclm-2018-0596. [Epub ahead of print]

PMID:
30218601
2.

Correction to: Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients.

Venturelli E, Orenti A, Fabricio ASC, Garrone G, Agresti R, Paolini B, Bonini C, Gion M, Berrino F, Desmedt C, Coradini D, Biganzoli E.

BMC Cancer. 2018 Sep 10;18(1):876. doi: 10.1186/s12885-018-4799-2.

3.

Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients.

Venturelli E, Orenti A, Fabricio ASC, Garrone G, Agresti R, Paolini B, Bonini C, Gion M, Berrino F, Desmedt C, Coradini D, Biganzoli E.

BMC Cancer. 2018 Jun 13;18(1):651. doi: 10.1186/s12885-018-4558-4. Erratum in: BMC Cancer. 2018 Sep 10;18(1):876.

4.

Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial.

Pastorelli D, Fabricio ASC, Giovanis P, D'Ippolito S, Fiduccia P, Soldà C, Buda A, Sperti C, Bardini R, Da Dalt G, Rainato G, Gion M, Ursini F.

Pharmacol Res. 2018 Jun;132:72-79. doi: 10.1016/j.phrs.2018.03.013. Epub 2018 Mar 31.

PMID:
29614381
5.

Human Chorionic Gonadotropin Assays for Testicular Tumors: Closing the Gap between Clinical and Laboratory Practice.

Ferraro S, Trevisiol C, Gion M, Panteghini M.

Clin Chem. 2018 Feb;64(2):270-278. doi: 10.1373/clinchem.2017.275263. Epub 2017 Oct 11. Review.

PMID:
29021329
6.

Decision making about healthcare-related tests and diagnostic test strategies. Paper 5: a qualitative study with experts suggests that test accuracy data alone is rarely sufficient for decision making.

Mustafa RA, Wiercioch W, Ventresca M, Brozek J, Schünemann HJ; DU-Diagnosis expert group.

J Clin Epidemiol. 2017 Dec;92:47-57. doi: 10.1016/j.jclinepi.2017.09.005. Epub 2017 Sep 14. Review.

PMID:
28917629
7.

Appropriateness of tumor marker request: a case of study.

Gion M, Trevisiol C, Fabricio ASC.

Ann Transl Med. 2017 Jul;5(13):274. doi: 10.21037/atm.2017.06.19.

8.

Epidemiology-based assessment of tumor marker overordering in breast cancer: an algorithm to examine different disease conditions.

Trevisiol C, Gion M, Dittadi R, Zappa M, Fabricio ASC.

Int J Biol Markers. 2017 Oct 31;32(4):e471-e473. doi: 10.5301/ijbm.5000274.

PMID:
28561878
9.

Indicators of inappropriate tumour marker use through the mining of electronic health records.

Gion M, Cardinali G, Trevisiol C, Zappa M, Rainato G, Fabricio ASC.

J Eval Clin Pract. 2017 Aug;23(4):895-902. doi: 10.1111/jep.12754. Epub 2017 May 15.

PMID:
28503788
10.

Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 3).

Gion M, Trevisiol C, Rutjes AWS, Rainato G, Fabricio ASC.

Int J Biol Markers. 2017 May 4;32(2):e147-e181. doi: 10.5301/ijbm.5000272. No abstract available.

PMID:
28475208
11.

Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 2).

Gion M, Trevisiol C, Rutjes AWS, Rainato G, Fabricio ASC.

Int J Biol Markers. 2017 Mar 2;32(1):e1-e52. doi: 10.5301/ijbm.5000259. No abstract available.

PMID:
28255982
12.

Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 1)

Gion M, Trevisiol C, Rutjes AW, Rainato G, Fabricio AS.

Int J Biol Markers. 2016 Dec 23;31(4):e332-e367. doi: 10.5301/jbm.5000251. No abstract available.

PMID:
28025819
13.

Need for knowledge translation to improve tumor marker application.

Gion M.

Int J Biol Markers. 2016 Dec 23;31(4):e331. doi: 10.5301/jbm.5000250. No abstract available.

PMID:
28025818
14.

Evaluating serum insulin-like growth factor 1 and insulin-like growth factor binding protein 3 as markers in prostate cancer diagnosis.

Rainato G, Fabricio AS, Zancan M, Peloso L, Dittadi R, Barichello M, Fandella A, Scattoni V, Gion M.

Int J Biol Markers. 2016 Jul 30;31(3):e317-23. doi: 10.5301/jbm.5000200.

PMID:
26954072
15.

HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study.

Romagnolo C, Leon AE, Fabricio ASC, Taborelli M, Polesel J, Del Pup L, Steffan A, Cervo S, Ravaggi A, Zanotti L, Bandiera E, Odicino FE, Scattolo N, Squarcina E, Papadakis C, Maggino T, Gion M.

Gynecol Oncol. 2016 May;141(2):303-311. doi: 10.1016/j.ygyno.2016.01.016. Epub 2016 Jan 19.

PMID:
26801941
16.

An epidemiology-based model as a tool to monitor the outbreak of inappropriateness in tumor marker requests: a national scale study.

Gion M, Peloso L, Trevisiol C, Squarcina E, Zappa M, Fabricio AS.

Clin Chem Lab Med. 2016 Mar;54(3):473-82. doi: 10.1515/cclm-2015-0329.

PMID:
26351929
17.

Are E-test and Vitek2 good choices for tigecycline susceptibility testing when comparing broth microdilution for MDR and XDR Acinetobacter baumannii?

Grandesso S, Sapino B, Amici G, Mazzucato S, Solinas M, Gion M.

New Microbiol. 2014 Oct;37(4):503-8. Epub 2014 Oct 1.

18.

The role of HE4 in ovarian cancer follow-up: a review.

Piovano E, Attamante L, Macchi C, Cavallero C, Romagnolo C, Maggino T, Landoni F, Gadducci A, Sartori E, Gion M, Zola P.

Int J Gynecol Cancer. 2014 Oct;24(8):1359-65. doi: 10.1097/IGC.0000000000000218. Review.

19.

Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms.

Italian Association of Hospital Gastroenterologists and Endoscopists; Italian Association for the Study of the Pancreas, Buscarini E, Pezzilli R, Cannizzaro R, De Angelis C, Gion M, Morana G, Zamboni G, Arcidiacono P, Balzano G, Barresi L, Basso D, Bocus P, Calculli L, Capurso G, Canzonieri V, Casadei R, Crippa S, D'Onofrio M, Frulloni L, Fusaroli P, Manfredi G, Pacchioni D, Pasquali C, Rocca R, Ventrucci M, Venturini S, Villanacci V, Zerbi A, Falconi M; Cystic Pancreatic Neoplasm Study Group.

Dig Liver Dis. 2014 Jun;46(6):479-93. doi: 10.1016/j.dld.2013.12.019. Epub 2014 May 5.

20.

Sirtuin 1 stabilization by HuR represses TNF-α- and glucose-induced E-selectin release and endothelial cell adhesiveness in vitro: relevance to human metabolic syndrome.

Ceolotto G, De Kreutzenberg SV, Cattelan A, Fabricio AS, Squarcina E, Gion M, Semplicini A, Fadini GP, Avogaro A.

Clin Sci (Lond). 2014 Oct;127(7):449-61. doi: 10.1042/CS20130439.

PMID:
24702436

Supplemental Content

Loading ...
Support Center